Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001437

Drug Information
SynonymsPrestwick0_000268; NCGC00021727-07; Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-; KBioGR_001430; ZINC19796031; Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-; (+)-Apovincaminic acid ethyl ester; SPBio_002335; NCGC00021727-06; TCV-3B; I06-1883; CHEBI:210947; Prestwick_963; KBio1_001367; 42971-09-5; NCGC00018204-05; BPBio1_000128; DivK1c_006423; Spectrum5_000966; Vinpocetinum; NCGC00021727-05; HMS1568F18; RGH 4405; LS-63711; Spectrum2_001529; KBioSS_001880; V 6383; cis-Apovincaminic acid ethyl ester; D01371; Ceractin; NCGC00021727-04; NCGC00018204-10; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv.; V6383_SIGMA; BRD-K53318339-001-05-8; (+)-cis-Apovincaminic acid ethyl ester; CID443955; Vinpocetine (JAN/USAN/INN); SMR000058241; AY 27255; Spectrum_001400; BSPBio_000116; AC1L9FGV; Spectrum4_001075; HMS2092L06; KBio2_007016; EINECS 256-028-0; ST056350; Apovincaminate d'ethyle [French]; Vinpocetine [USAN:INN:JAN]; HMS2090J22; SPBio_001318; Spectrum3_000961; Vinpocetine-ethyl apovincaminate; Eburnamenine-14-carboxylic acid ethyl ester; AY 27,255; Ethyl (+)-apovincaminate; EU-0101257; BSPBio_002561; KBio2_004448; 3-alpha,16-alpha-Apovincaminic acid ethyl ester; Prestwick3_000268; Prestwick1_000268; KBio3_001781; Cavinton; TCV 3B; C22H26N2O2; ethyl apovincaminate, (3alpha,16alpha)-isomer; NCGC00168782-01; SPECTRUM1503115; Ultra-Vinca; MLS000069635; KBio2_001880; Bravinton; Eburnamenine-14-carboxylic acid ethyl ester;; Ethyl (+)-cis-apovincaminate; HMS1922G05; Vinpocetinum [INN-Latin]; Ethyl apovincamin-22-oate; ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate; (3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester; MLS001076294; Prestwick2_000268; Apovincaminate d'ethyle; CHEMBL71752; Lopac0_001257; vinpocetine; Apovincaminic acid ethyl ester; SpecPlus_000327; MolPort-003-666-450; BRN 0900803; RGH-4405; 115986-87-3
Trade NameCavinton; Intelectol
IndicationAcute ischaemic stroke
[ICD9: 434.91   ICD10: I61-I63]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC    
Isomeric SMILESCC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC
Therapeutic ClassVasodilator Agents
CAS NumberCAS 42971-09-5
PubChem Compound IDCID 443955.
PubChem Substance IDSID 180367.
SuperDrug ATC IDN06BX18
SuperDrug CAS ID042971095;
TargetCalcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1Inhibitor[1]
Ref 1Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissue. Urology. 2009 Jun;73(6):1397-401. Epub 2009 Mar 13. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543